Purpose: To identify risk factors for and outcomes in acute respiratory distress syndrome (ARDS) in patients hospitalized with community-acquired pneumonia (CAP). Methods: This is a retrospective study using the Premier Healthcare Database between 2016 and 2020. Patients diagnosed with pneumonia, requiring mechanical ventilation (MV), antimicrobial therapy, and hospital admission ≥2 days were included. Multivariable regression models were used for outcomes including in-hospital mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, and days on MV. Results: 1924 (2.7%) of 72 107 patients with CAP developed ARDS. ARDS was associated with higher mortality (33.7% vs 18.9%; adjusted odds ratio 2.4; 95% confidence interval [CI] 2.16-2.66), longer hospital LOS (13 vs 9 days; adjusted incidence risk ratio (aIRR) 1.24; 95% CI 1.20-1.27), ICU LOS (9 vs 5 days; aIRR 1.51; 95% CI 1.46-1.56), more MV days (8 vs 5; aIRR 1.54; 95% CI 1.48-1.59), and increased hospitalization cost ($46 459 vs $29 441; aIRR 1.50; 95% CI 1.45-1.55). Conclusion: In CAP, ARDS was associated with worse in-patient outcomes in terms of mortality, LOS, and hospitalization cost. Future studies are needed to explore outcomes in patients with CAP with ARDS and explore risk factors for development of ARDS after CAP.
PfuntnerAWierLMStocksC. Most frequent conditions in U.S. hospitals, 2011. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. NIH Agency for Healthcare Research and Quality (US); 2006. Brief #162
2.
XuJMurphySLKochanekKDBastianBA. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64(2):1-119.
3.
RamirezJAWiemkenTLPeyraniP, et al.Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806-1812.
4.
NairGBNiedermanMS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther.2021;217:107663.
5.
WoodheadMWelchCAHarrisonDABellinganGAyresJG. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC case mix programme database. Crit Care. 2006;10(Suppl 2):S1.
6.
SliglWIEurichDTMarrieTJMajumdarSR. Age still matters: prognosticating short- and long-term mortality for critically ill patients with pneumonia. Crit Care Med. 2010;38(11):2126-2132.
7.
CillónizCEwigSFerrerM, et al.Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care. 2011;15(5):R209.
8.
VillarJBlancoJAñónJM, et al.The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37(12):1932-1941.
9.
AmatoMBPMeadeMOSlutskyAS, et al.Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med.2015;372(8):747-755.
10.
BellaniGLaffeyJGPhamT, et al.Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788-800.
11.
ZilberbergMDEpsteinSK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1159-1164.
12.
RosenthalNCaoZGundrumJSianisJSafoS. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058.
13.
HaesslerSGuoNDeshpandeA, et al.Etiology, treatments, and outcomes of patients with severe community-acquired pneumonia in a large U.S. sample. Crit Care Med. 2022;50(7):1063-1071.
14.
KlompasMImreyPBYuPC, et al.Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2021;42(7):817-825.
15.
MooreBJWhiteSWashingtonRCoenenNElixhauserA. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care. 2017;55(7):698-705.
16.
BrarNKNiedermanMS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5(1):61-78.
17.
DaiQWangSLiuRWangHZhengJYuK. Risk factors for outcomes of acute respiratory distress syndrome patients: a retrospective study. J Thorac Dis. 2019;11(3):673-685.
18.
SigurdssonMISigvaldasonKGunnarssonTSMollerASigurdssonGH. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand.2013;57(1):37-45.
19.
HasanSSCapstickTAhmedR,et al.Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(11):1149-1163.
20.
FanTHHuangMGedanskyA,et al.Prevalence and outcome of acute respiratory distress syndrome in traumatic brain injury: a systematic review and meta-analysis. Lung. 2021;199(6):603-610.
21.
XuHShengSLuoWXuXZhangZ. Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup. Front Immunol.2023;14:1277161.
22.
ParharKKSZjadewiczKSooA, et al.Epidemiology, mechanical power, and 3-year outcomes in acute respiratory distress syndrome patients using standardized screening. An observational cohort study. Ann Am Thorac Soc. 2019;16(10):1263-1272.
23.
RestrepoMIMortensenEMVelezJAFreiCAnzuetoA. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133(3):610-617.
24.
SawadaYSasabuchiYNakaharaY,et al.Early rehabilitation and in-hospital mortality in intensive care patients with community-acquired pneumonia. Am J Crit Care.2018;27(2):97-103.
25.
EspinozaRe SilvaJRLBergmannA,et al.Factors associated with mortality in severe community-acquired pneumonia: a multicenter cohort study. J Crit Care.2019;50:82-86.
26.
EurichDTMarrieTJMinhas-SandhuJKMajumdarSR. Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am J Respir Crit Care Med.2015;192(5):597-604.
27.
TobaAYamazakiMMochizukiH,et al.Lower incidence of acute respiratory distress syndrome in community-acquired pneumonia patients aged 85 years or older. Respirology. 2010;15(2):319-325.
28.
SirventJMCarmen de la TorreMLorencioC,et al.Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24h of ICU admission. Med Intensiva. 2013;37(5):308-315.
29.
CillonizCFerrerMLiapikouA, et al.Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia. Eur Respir J. 2018;51(3):1702215.
30.
ChenC-YLeeC-HLiuC-YWangJ-HWangL-MPerngR-P. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc.2005;68(1):4-10.
31.
TreggiariMMHudsonLDMartinDPWeissNSCaldwellERubenfeldG. Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med.2004;32(2):327-331.
32.
BaiJFügenerASchoenfelderJBrunnerJO. Operations research in intensive care unit management: a literature review. Health Care Manag Sci.2018;21(1):1-24.
33.
KaierKHeisterTWolffJWolkewitzM. Mechanical ventilation and the daily cost of ICU care. BMC Health Serv Res.2020;20(1):267.
34.
WuJYStollingsJLWheelerAPSemlerMWRiceTW. Efficacy and outcomes after vasopressin guideline implementation in septic shock. Ann Pharmacother.2016;51(1):13-20.
35.
LamSWBarretoEFScottRKashaniKBKhannaAKBauerSR. Cost-effectiveness of second-line vasopressors for the treatment of septic shock. J Crit Care.2020;55:48-55.
36.
DremsizovTClermontGKellumJAKalassianKGFineMJAngusDC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?Chest. 2006;129(4):968-978.
37.
EworukeEMajorJMGilbert McClainLI. National incidence rates for acute respiratory distress syndrome (ARDS) and ARDS cause-specific factors in the United States (2006–2014). J Crit Care.2018;47:192-197.
38.
SubramanianSYilmazMRehmanAHubmayrRDAfessaBGajicO. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Intensive Care Med. 2008;34(1):157-162.
39.
ZimmerCBeiderlindenMPetersJ. Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis. Clin Rheumatol.2006;25(3):430-432.
40.
KhajaMMenonLNiaziMFuentesGD. Diffuse alveolar hemorrhage and acute respiratory distress syndrome during treatment of rheumatoid arthritis with etanercept. J Bronchology Interv Pulmonol.2012;19(3):228-231.
41.
GowerJLabarcaGEnosDNova-LampertiE. Rapid development of severe acute respiratory distress syndrome after Abatacept treatment in a patient with rheumatoid arthritis. BMJ Case Rep. 2020;13(4):e231725.
42.
MoelantsEAVMortierAVan DammeJProostP. Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol. 2013;91(6):393-401.
43.
HussainMKhurram SyedSFatimaM, et al.Acute respiratory distress syndrome and COVID-19: a literature review. J Inflamm Res.2021;14(null):7225-7242.
44.
BhatiaMMoochhalaS. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol.2004;202(2):145-156.
45.
TorresAPeetermansWEViegiGBlasiF. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057-1065.
46.
AlmirallJBolíbarISerra-PratM, et al.New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J.2008;31(6):1274-1284.
47.
AlmirallJSerra-PratMBolíbarIBalassoV. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299-311.
48.
FarrBMBartlettCLRWadsworthJMillerDL. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. Respir Med.2000;94(10):954-963.
49.
KasotakisGStanfieldBHainesK,et al.Acute respiratory distress syndrome (ARDS) after trauma: improving incidence, but increasing mortality. J Crit Care. 2021;64:213-218.
50.
LiSZhaoDCuiJWangLMaXLiY. Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis. J Int Med Res. 2020;48(2):300060519895659.
51.
FergusonNDFanECamporotaL, et al.The Berlin definition of ARDS: an expanded rationale, justification, and supplemental material. Intensive Care Med.2012;38(10):1573-1582.
